Safety of NovoMix 30 (Biphasic Insulin Aspart) Treatment in Patients With Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 20 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 20 May 2010 Actual patient number (185) added as reported by ClinicalTrials.gov.